The genetics of Parkinson disease: Implications for neurological care.
about
Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screenBiochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1)A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2Emerging preclinical pharmacological targets for Parkinson's diseaseGenetics of Parkinson's diseaseMitochondrial dysfunction and oxidative stress in Parkinson's diseaseMechanisms of mitophagyGenetics in Parkinson disease: Mendelian versus non-Mendelian inheritanceNetwork Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the DiseaseHow Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend InitiativeThe effects of oxidative stress on parkin and other E3 ligases.Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway.Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.Imaging genetics approach to Parkinson's disease and its correlation with clinical score.Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study.Genetic tests: between risks and opportunities. The case of neurodegenerative diseases.ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells.Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.Olfactory dysfunction in LRRK2 G2019S mutation carriersGender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest.Phenome-based gene discovery provides information about Parkinson's disease drug targetsCo-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutationsLipid profiling of parkin-mutant human skin fibroblasts.Phosphatidylethanolamine Metabolism in Health and Disease.Comparative deletion mapping at 1p31.3-p32.2 implies NFIA responsible for intellectual disability coupled with macrocephaly and the presence of several other genes for syndromic intellectual disability.GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein.AMPA receptor-dependent H2O2 generation in striatal medium spiny neurons but not dopamine axons: one source of a retrograde signal that can inhibit dopamine releaseParkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.Recognition and management of Parkinson's disease during the premotor (prodromal) phase.Neurotrophic natural products: chemistry and biology.A network view on Parkinson's disease.ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders.Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.Considerations regarding the etiology and future treatment of autosomal recessive versus idiopathic Parkinson disease.Can parkin be a target for future treatment of Parkinson's disease?Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
P2860
Q24300657-E5147393-1576-48D2-B818-A5224273A56FQ24307730-27DF6572-1553-4B73-84BB-70E0C6EEE9C2Q24319028-A5EF56DF-1D3A-4546-B9A8-1C5C16F77649Q26764724-E5957FD7-3892-410D-830A-1778BBB57ADAQ26827825-C92DCB7A-36C2-4C38-ABB5-4227175C0388Q27014051-A35B3761-8208-42CD-BC39-D909C5037B2FQ27310261-0BC79177-4572-4679-8101-E626A1EB09C4Q28077356-488526AE-A770-4EB4-8F58-08D7D78533FEQ28552595-8810DAB7-0405-45C0-9608-DDC26D3AA698Q28601451-47C97D73-059F-440F-8139-3C1F57A5029FQ30273796-942A8D9D-F9C5-4EF4-9F28-614078256469Q30438387-34F69098-F1EE-4460-BACF-E7B990489FCBQ30438950-0F995AE4-04B5-409F-B40B-08B3953EB760Q33326619-29E58AB4-F9E9-4967-9E23-42CB4CBEA20FQ33587357-D1D0B46F-DFCD-4870-BB8E-21F728137043Q33644322-7103BF57-C62D-4B20-949D-ADC5AD92DCD0Q33802254-926286A0-04B9-4C9A-BBD0-5225F4860167Q34394852-1A910F7A-102B-401A-9B39-766F6069640FQ34774337-11D844DF-A4CA-437E-917E-C45CE531ADEDQ34883582-A490F7D5-9565-40C3-A085-A028DC6158A5Q35119617-ECF3EC0D-CA6D-41B8-85E2-662600F2F71CQ35643374-B15B2DEC-549B-4333-804B-89E8AC9AAC82Q35758762-2DCCC556-2B17-4B9D-B79C-07672EBDE5B8Q36120753-038AA90B-3C20-46E8-85EF-BAF5D085147EQ36227376-B21AF469-7BCB-4A0B-A63E-2385932B111DQ36256274-842A2ED7-B46D-44E7-99FE-064D9C6E1FB8Q36652965-E4BA7DD6-7142-43E5-AC97-4030200F2FD1Q36700817-A7B2C52E-1AC5-4D6F-B7D0-8DFDFDA630D0Q36825286-4B55EDA5-EC7B-44D0-80EE-017DF7145FEEQ36893230-BA9DE3E3-7888-407D-B222-B35B5D2585EEQ37337917-FD2FFB7E-862C-45AF-8929-B46DBE3058D5Q37507968-BF64BA46-CC9A-43BE-B5D1-9B261EE7C235Q37623342-163E731B-E058-4CA4-B41C-8892492183DFQ37655091-A8D8A7AC-BC45-45EE-A69E-F8010E747BE3Q37789041-D54F02A2-A662-4DFC-ADF3-CF2E913F0C07Q37809870-F211B0A4-0155-47D7-A6A7-418C6F2FB088Q38006645-0D9507E2-2AAC-4AB2-B6C2-CB75C602CF6FQ38127703-CA61A8A4-F8D7-48C0-8925-E631E720E93BQ38265101-F84D8A31-2D9A-45B1-AB57-54E50EABD77DQ38772904-A54AFD85-81FC-46A0-BD73-27513D2D8B6B
P2860
The genetics of Parkinson disease: Implications for neurological care.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The genetics of Parkinson disease: Implications for neurological care.
@ast
The genetics of Parkinson disease: Implications for neurological care.
@en
type
label
The genetics of Parkinson disease: Implications for neurological care.
@ast
The genetics of Parkinson disease: Implications for neurological care.
@en
prefLabel
The genetics of Parkinson disease: Implications for neurological care.
@ast
The genetics of Parkinson disease: Implications for neurological care.
@en
P2860
P356
P1476
The genetics of Parkinson disease: Implications for neurological care.
@en
P2093
Michael G Schlossmacher
P2860
P304
P356
10.1038/NCPNEURO0126
P577
2006-03-01T00:00:00Z